| Robert Clinton Fatter, MD | |
|
1505 N Main St, Belton, TX 76513-1907 | |
| (254) 724-2111 | |
| Not Available |
| Full Name | Robert Clinton Fatter |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1505 N Main St, Belton, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407115256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | P8897 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seton Family Of Doctors | 0941333280 | 663 |
News Archive
When we think about the powers of testosterone, we usually do not consider mental processes.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today commented that the Notice of Proposed Rule Making issued last week on electronic health record (EHR) incentive programs moves the healthcare industry closer to securing American Recovery and Reinvestment Act (ARRA) stimulus payments for healthcare IT adoption.
In September 2014, President Obama issued an executive order for "Combating Antibiotic- Resistant Bacteria." Why the urgency? The Centers for Disease Control and Prevention, the order noted, "estimates that annually at least 2 million illnesses and 23,000 deaths are caused by antibiotic- resistant bacteria in the United States alone."
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
› Verified 9 days ago
| Entity Name | Seton Family Of Doctors |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588997233 PECOS PAC ID: 0941333280 Enrollment ID: O20100806000260 |
News Archive
When we think about the powers of testosterone, we usually do not consider mental processes.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today commented that the Notice of Proposed Rule Making issued last week on electronic health record (EHR) incentive programs moves the healthcare industry closer to securing American Recovery and Reinvestment Act (ARRA) stimulus payments for healthcare IT adoption.
In September 2014, President Obama issued an executive order for "Combating Antibiotic- Resistant Bacteria." Why the urgency? The Centers for Disease Control and Prevention, the order noted, "estimates that annually at least 2 million illnesses and 23,000 deaths are caused by antibiotic- resistant bacteria in the United States alone."
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Clinton Fatter, MD Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Robert Clinton Fatter, MD 1505 N Main St, Belton, TX 76513-1907 Ph: (254) 724-2111 |
News Archive
When we think about the powers of testosterone, we usually do not consider mental processes.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today commented that the Notice of Proposed Rule Making issued last week on electronic health record (EHR) incentive programs moves the healthcare industry closer to securing American Recovery and Reinvestment Act (ARRA) stimulus payments for healthcare IT adoption.
In September 2014, President Obama issued an executive order for "Combating Antibiotic- Resistant Bacteria." Why the urgency? The Centers for Disease Control and Prevention, the order noted, "estimates that annually at least 2 million illnesses and 23,000 deaths are caused by antibiotic- resistant bacteria in the United States alone."
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
› Verified 9 days ago
Everett L Warthan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3500 S Ih 35, Belton, TX 76513 Phone: 254-939-2100 | |
Dr. Adam Joseph Rindfleisch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1505 N Main St, Belton, TX 76513 Phone: 254-933-4000 Fax: 254-933-4016 | |
Dr. Stephen Jay Sewell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Arbor Park, Belton, TX 76513 Phone: 254-933-4100 Fax: 254-831-2001 | |
Mrs. Melinda Diane Mcgurk, FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1001 Arbor Park, Belton, TX 76513 Phone: 254-831-2000 Fax: 254-831-2001 | |
Dr. Andrew Montgomery Dale, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 207 Lake Rd, Belton, TX 76513 Phone: 979-475-8334 | |
Dallas Elwood Peterson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Arbor Park, Belton, TX 76513 Phone: 254-933-4100 |